CRISPR-Cas systems provide sequence-specific immunity against phages and mobile 9 genetic elements using CRISPR-associated nucleases guided by short CRISPR RNAs (crRNAs). 10
Introduction 22
Nearly all known archaea and about half of bacteria possess adaptive immune systems 24 composed of clusters of regularly-interspaced short palindromic repeats (CRISPRs) and CRISPR-25 associated (Cas) proteins (Makarova et al., 2015) . CRISPR-Cas systems utilize small CRISPR RNAs 26 (crRNAs) to recognize and destroy prokaryotic viruses (phages) ( to record a molecular memory of past invaders. During crRNA biogenesis, the repeats and 34 spacers are transcribed into a long precursor crRNA, which is subsequently processed to 35 generate mature crRNAs that each contain a single spacer sequence. Mature crRNAs combine 36 with one or more Cas proteins to form an effector complex, which during interference, senses 37 and degrades "protospacers", invading nucleic acids complementary to the crRNA. Although all 38 CRISPR-Cas systems adhere to this general pathway, they exhibit striking diversity in their cas 39 gene composition and corresponding mechanisms of action. Accordingly, the current 40 classification scheme divides these systems into two classes, six Types (I-VI), and dozens of 41 subtypes (Koonin, Makarova, & Zhang, 2017; Makarova et al., 2015) . Class 1 systems (Types I, 42 6 S1), indicating that PNPase is indeed required for efficient crRNA maturation. To rule out the 138 possibility of an unintentional second-site mutation causing this phenotype, we created a 139 complementation strain in which pnp was re-introduced into the genome of the knockout 140 strain, along with several silent mutations in the coding region (denoted as pnp*) to 141 differentiate between the original wild-type and knock-in strains (Fig. S2 ). As expected, the 142 crRNA size distribution returned to the wild-type phenotype in the complementation strain (Fig. 143 2 B and C and Table S1), providing confirmation that efficient crRNA maturation relies upon the 144 activity of PNPase. 145
The persistence of residual maturation in the Dpnp mutant suggests there are probably 146 additional nuclease(s) contributing to this process. In order to identify other maturation 147 nuclease candidates, we consulted the short list of cellular nucleases that were previously 148 found to co-purify with the Cas10-Csm complex . Now, after having 149 established a bona fide function for PNPase in crRNA maturation, two other co-purifying 150 nucleases emerged as promising candidates: Ribonucleases J1 and J2. Since PNPase, RNase J1, 151
and RNase J2 have all been found to work together as components of the degradosome in gram 152 positive organisms (Cho, 2017; Redder, 2018; Roux, DeMuth, & Dunman, 2011) , the possibility 153 exists that they might also be working together in the CRISPR-Cas10 immunity pathway. 154
Additionally, the gene encoding RNase J2, rnjB, is located directly downstream of pnp in the S. 155 epidermidis genome, further hinting at a functional link. Ribonucleases J1 and J2 are paralogous 156 enzymes that have been shown to form a complex in the cell and catalyze endonucleolytic and temperature sensitivity that has been observed in a S. aureus DrnjA mutant (Hausmann et al., 167 2017). Nonetheless, we were able to create an in-frame deletion of rnjB, the gene that encodes 168 RNase J2, in both S. epidermidis RP62a and LM1680 strains ( Fig. S1 ). To test for defects in crRNA 169 maturation in the LM1680/DrnjB mutant, we overexpressed and purified Cas10-Csm complexes 170 from this strain and extracted and visualized the complex-associated crRNAs (Fig. 2) . We 171 observed that Cas10-Csm remains intact when expressed in the DrnjB background ( Fig. 2A) , and 172 the crRNA size distribution is similar to that observed in the wild-type control (Fig. 2 B and C 173 and Table S1 ), indicating that RNase J2 is unlikely to be involved in crRNA maturation. To 174 confirm, we also created the DpnpDrnjB double-mutant ( Fig. S1 ) and found that it exhibits a 175 maturation defect similar to that observed in the Dpnp single mutant ( Fig. 2 B and C) . From 176 these observations, it can be concluded that PNPase, but not RNase J2, is essential for efficient 177 crRNA maturation, and that there exist other maturation nuclease(s) that have yet to be 178 identified. 179 180
RNaseJ2 is required for CRISPR-Cas10 mediated anti-plasmid and anti-phage immunity 181
We next wondered whether the activities of PNPase and/or RNase J2 are essential for 182 CRISPR-Cas10 function. To test this, three independent interference assays against diverse 183 mobile genetic elements were conducted ( Fig. 3) . 184
The first is a plasmid challenge assay that measures the transfer efficiency of the 185 conjugative plasmid pG0400 from a S. aureus donor into S. epidermidis LM1680 recipients 186 bearing pcrispr-cas ( Fig. 3A ). In this system, spc1 (the first spacer) targets the nickase gene in 187 pG0400, therefore, a functional CRISPR-Cas10 system in the recipient strain is expected to 188 lower the conjugation efficiency. Indeed, the controls behaved consistently with previous 189 results (Hatoum-Aslan et al., 2013), where the wild-type LM1680 strain bearing the empty 190 vector (pC194) showed a conjugation efficiency in the 10 -3 range, while this same strain 191 harboring pcrispr-cas exhibited an efficiency in the 10 -7 range ( Fig. 3B and Table S2 ). 192
Interestingly, despite the maturation defect in Dpnp/pcrispr-cas, this strain had a conjugation 193 efficiency similar to that of the wild-type strain expressing the CRISPR-Cas10 system, suggesting 194 that PNPase is dispensable for anti-plasmid immunity. In contrast, DrnjB/pcrispr-cas exhibited a significant defect in immunity, with a conjugation efficiency similar to that of the negative 196 control. Consistent with this result, DpnpDrnjB/pcrispr-cas showed a similar defect. Furthermore, complementation strains containing a copy of rnjB on pcrispr-cas (a plasmid 198 called pcrispr-cas-rnjB) exhibited conjugation efficiencies similar to those of the wild-type strain 199 bearing pcrispr-cas ( Fig. 3B and Table S2 ). These observations suggest that RNase J2 is essential 200 for CRISPR-Cas10 anti-plasmid immunity. 201
To determine if this defect applies specifically to plasmid transfer, or if there is a more 202 general phenotype, we tested CRISPR immunity against two unrelated phages. The first, CNPx, 203 is a variant of CNPH82, a temperate phage belonging to the morphological family Siphoviridae 204 (Daniel, Bonnen, & Fischetti, 2007; Maniv et al., 2016) . CNPx can infect S. epidermidis LM1680, 205 and spc2 in pcrispr-cas bears complementarity to its cn20 gene ( Fig. 3C ). When dilutions of this 206 phage are plated with the LM1680/pC194 negative control, many plaques, or zones of clearing 207 in the bacterial lawn can be observed, approximately 10 7 plaque-forming units per milliliter 208 (pfu/ml) ( Fig. 3D and Table S3 ). However, when the LM1680/pcrispr-cas strain is challenged 209 with CNPx, not a single plaque is visible, in agreement with the robust anti-phage immunity 210 previously reported for this system (Bari et al., 2017; Pyenson et al., 2017) . Importantly, when 211 we challenged the mutant strains with CNPx, we saw phenotypes similar to those observed for 212 anti-plasmid immunity: While the Dpnp strain appeared to perform like wild-type, the DrnjB 213 and DpnpDrnjB mutations abolished CRISPR-Cas10 function. In addition, returning rnjB to these 214 defective mutants on pcrispr-cas-rnjB restored full immunity against CNPx. 215
Finally, we wanted to determine if the phenotypes observed thus far are specific to 216 important to note that this system relies upon the RP62a genome-encoded cas and csm genes, 225 with only the Andhra-targeting spacer being overexpressed on the plasmid. As expected, 226 without pcrispr-spcA2, all strains are equally susceptible to Andhra, with plaque counts ranging 227 between 10 8 -10 9 pfu/ml ( Fig. 3F and Table S4 ). However, when transformed with pcrispr-228 spcA2, only the wild-type and Dpnp strains gain complete immunity to Andhra, while the DrnjB 229 and DpnpDrnjB strains remain as sensitive to Andhra as the corresponding negative controls 230 without the pcrispr-spcA2 plasmid. From these collective observations, we can conclude that 231 while PNPase appears dispensable, RNase J2 is essential for CRISPR immunity against diverse 232 mobile genetic elements originating from plasmid and phage. In addition, RNase J2 most likely 233 acts in the CRISPR pathway at a step downstream of crRNA maturation. 234
235

PNPase and RNase J2 promote the efficient clearance of phage-derived nucleic acids 236
Although CRISPR immunity appeared unperturbed in the Dpnp mutant, we wondered if 237 a partial defect might be present which cannot be resolved by the functional assays. For 238 example, a partial defect in anti-plasmid immunity might lead to a decrease in plasmid copy 239 number instead of complete elimination, but the copy number reduction might be sufficient to 240 prevent growth on the media that selects for transconjugants. Similarly, a partial defect in anti-241 phage immunity might result in the survival of a small number of phages, but too few to create 242 a visible plaque in the lawn of bacteria. In order to detect such partial defects in immunity, we 243 used qPCR and qRT-PCR (quantitative PCR and reverse-transcriptase PCR, respectively) to 244 measure DNA and RNA accumulation during an active phage infection. Of the three systems for 245 testing CRISPR function, the RP62a-Andhra system ( Fig. 3E ) was selected for this assay for two 246 reasons: First, RP62a is the original clinical isolate containing a single genomic copy of the 247 CRISPR-Cas10 system, thus providing the closest approximation to what might naturally occur. 248 Second, Andhra is strictly lytic and therefore expected to express all genes in a single infection 249 cycle (Cater et al., 2017). The latter feature eliminates any gene-specific variations in CRISPR-250
Cas10 function that would otherwise occur using a temperate phage (Goldberg et al., 2014; 251 Jiang et al., 2016). In the assay (Fig. 4A ), early-log cells were challenged with Andhra in a 2:1 252 (bacteria:phage) ratio, and phages were allowed to adsorb to cells for 10 minutes. Infected cells 253 were then washed with fresh media to remove any phages in suspension. A fraction of the cells 254 was harvested immediately after adsorption (time = 0 min) and every ten minutes thereafter 255 for up to 30 minutes. Importantly, the latent period for Andhra was previously determined to 256 be 35 minutes (Cater et al., 2017), therefore the selected time points all occur within the 257 timeframe of a single infection cycle before the first burst. Immediately after each harvest, cells 258 were heat-killed to prevent any further changes in nucleic acid content, and then subjected to 259 nucleic acid extraction. The RNA and DNA extracts were analyzed by qRT-PCR and qPCR, 260 respectively, using two pairs of primers: Andhra-specific primers that flank the protospacer 261 region within gene gp09 ( Fig. S3 A) , and genome-specific primers that bind the gap gene 262 (encodes glyceraldehyde-3-phosphate dehydrogenase) for normalization. For quantification, 263 the relative abundance of the phage-derived PCR product detected at zero minutes post-264 infection in RP62a cells was set to 1 as the reference point. 265
As expected, in wild-type RP62a cells lacking spcA2, phage RNA and DNA levels 266 increased significantly in a time-dependent manner ( Fig. 4 B and C and Tables S5 and S6); 267 however, the same strain bearing pcrispr-spcA2 exhibited a ten-fold depletion in phage RNA 268 levels, and no increase in phage DNA content by 30 minutes post-infection. Interestingly, the 269 Dpnp/pcrispr-spcA2 strain showed a significant (~10-fold) accumulation of phage RNA and DNA, 270 but not as high as that observed in the negative control strain devoid of pcrispr-spcA2. These 271 results suggest that PNPase is indeed required to promote efficient clearance of phage-derived 272 nucleic acids. We also tested the DrnjB/pcrispr-spcA2 and DpnpDrnjB/pcrispr-spcA2 strains, and 273 in agreement with their impaired CRISPR-Cas10 function, both strains showed significant 274 accumulation of phage-derived DNA and transcripts when compared to the wild-type strain 275 bearing pcrispr-spcA2. Notably, the double mutant showed a greater defect in the clearance of 276 phage nucleic acids than the DrnjB single mutant, thus confirming the contribution of PNPase 277 towards phage nucleic acid degradation. 278
One additional observation in this dataset was striking: The relative amounts of phage 279 nucleic acids in the DrnjB/pcrispr-spcA2 and DpnpDrnjB/pcrispr-spcA2 strains significantly targeting. To test this possibility, we conducted the same time course infection assay in the 283
Dpnp and DrnjB mutants lacking pcrispr-spcA2 and tracked DNA accumulation ( Fig. S3B and Table S7 ). As expected, the RP62a wild-type control showed that by 30 minutes post-infection, 285 phage DNA levels rose to ~35 times greater than that seen immediately following adsorption. To test the nucleolytic activities of the S. epidermidis RNases J homologs, we 309 overexpressed and purified recombinant RNase J1 and RNase J2 from E. coli (Fig. 5A) . In 310 addition, since previous reports have indicated that the dominant active site in an RNase J1/J2 311 complex resides within RNase J1 (Mathy et al., 2007 (Mathy et al., , 2010 , we also purified a catalytically-dead 312 variant of RNase J1 (denoted as dJ1) bearing H74A and H76A mutations. We first tested for 313 metal-dependent RNase activity in these enzymes by combining them with a 31 nt RNA 314 substrate ( Fig. 5B ) in the presence of various metals ( Table S8 ). Furthermore, the catalytically-dead RNase J1 mutant combined with RNase J2 324 showed no nucleolytic activity, confirming that the nuclease active site in the J1/J2 complex 325 originates from RNase J1. 326
We next tested for metal-dependent DNase activity in these enzymes by combining 327 them with a 60 nt DNA substrate ( other, and also have the potential to recruit and regulate other enzymes with relevant 351 functions to ensure a successful defense. Here, we show that the degradosome-associated 352 nuclease PNPase promotes crRNA maturation ( Fig. 2) and is required for the efficient CRISPR-353 mediated clearance of invading DNA and RNA (Fig. 4 ). We also show that a second 354 degradosome nuclease, RNase J2, is essential for CRISPR immunity against diverse mobile 355 genetic elements originating from plasmid and phage ( Fig. 3 ). Although bacterial RNase J 356 homologs have been strictly reported as ribonucleases, we present, to our knowledge, the first 357 demonstration of DNA degradation by these enzymes (Fig. 5 ). Altogether, our results support a 358 model for CRISPR-Cas10 immunity in which two of the three steps of the pathway, crRNA 359 biogenesis and interference, rely upon the activities of these degradosome-associated 360 nucleases (Fig. 6) . 361
We previously showed that Csm5 binds directly to PNPase and stimulates its nucleolytic be an additional, more direct interaction between RNase J2 and one or more of the CRISPR-370 associated proteins that has yet to be identified. Another compatible alternative is that RNase 371 J2 and/or PNPase might locate and degrade phage-derived nucleic acids through a CRISPR-372 independent mechanism. In support of this notion, we observed that in the absence of a 373 targeting CRISPR-Cas system, the deletion of pnp and rnjB enables significant phage DNA 374 accumulation which exceeds phage DNA levels in the wild-type strain by 10-40 fold, 375 respectively (Fig. S3B ). The mechanism by which these degradosome-associated nucleases 376 repress phage DNA replication in the absence of CRISPR interference remains unclear. has yet to be demonstrated. Therefore, our discovery that RNase J2 is essential for CRISPR-392
Cas10 immunity, combined with the fact that this enzyme is capable of promoting robust DNA 393 endonuclease cleavage ( Fig. 5H ), opens the possibility that the RNase J homologs assist with 394 (to select for S. epidermidis cells), 5 µg/ml mupirocin (to select for pG0400), 30 µg/ml 428 chloramphenicol (to select for E. coli BL21 (DE3)) and 50 µg/ml kanamycin (to select for pET28b-429
His10Smt3-based plasmids). Phages CNPx and Andhra were grown on S. epidermidis LM1680 430 and S. epidermidis RP62a host cells, respectively. To propagate phages, overnight cultures of 431 each host were diluted 1:100 in BHI supplemented with 5 mM CaCl2 and phage (1 x 10 7 pfu). 432
Cultures were incubated at 37°C with agitation for 5 h. One-fifth the volume of fresh mid-log 433 host cells was then added into the bacteria:phage culture, and the culture was incubated for an 434 additional 2 h at 37°C with agitation. Cells were pelleted at 5,000 x g for 5 min at 4°C, and the 435 and F331-334 (for pKOR1_Dpnp) and F452-F457 (for pKOR1_DrnjB) (Table S10 ). For 451 pKOR1_DpnpDrnjB, 1.0 kb DNA fragments flanking both genes were obtained via PCR 452 amplification using the S. epidermidis RP62a Dpnp strain as template and primers F452, F459, 453 F455-F457, and F460. For all constructs, the pKOR1 plasmid was used as a template to amplify 454
To create the complementation plasmid pKOR1_pnp*, a two-piece Gibson assembly was used, 457 wherein the pnp gene was amplified from S. epidermidis RP62a and assembled with the 458 pKOR1_Δpnp backbone generated with primers L047-L050. All assembled constructs were 459 transformed via electroporation into S. aureus RN4220. Four transformants were selected for 460 each construct and confirmed to harbor the plasmid using PCR and DNA sequencing with 461 primers F016, F181, F182, F335, and L009 (Table S10) used to propagate phage CNPx as described above. Filtered phage lysates were then diluted 471 1:10 in mid-log S. epidermidis RP62a cells. The phage:cell mixture was incubated at 37°C for 20 472 min, and pelleted at 5,000 x g for 5 min at 4°C. Cell pellets were resuspended in fresh BHI and 473 plated onto BHI agar containing neomycin and chloramphenicol. Plates were incubated 474 overnight at 30°C. Four colonies were picked and confirmed to harbor the plasmid by 475 subjecting them to PCR and sequencing using the appropriate sequencing primers listed in 476 Table S10 . 477 478 Generation of S. epidermidis mutants. Allelic replacement was used to generate all mutants 479 (Bae & Schneewind, 2006) . Briefly, S. epidermidis strains bearing pKOR1_Dpnp, pKOR1_DrnjB, 480 pKOR1_DpnpDrnjB, or pKOR1_pnp* were grown overnight at 30°C. Overnight cultures were 481 streaked onto BHI agar plates containing neomycin and chloramphenicol, and incubated 482 overnight at 43°C to force plasmid integration into the genome. Several colonies were then 483 inoculated into separate tubes containing fresh BHI broth supplemented with neomycin, and The overnight cultures were diluted 100,000 times with sterile water, and 100 µL of diluted 486 culture was plated onto BHI agar plates containing neomycin and anhydrotetracycline (50 487 ng/µl) and incubated overnight at 37°C to force plasmid loss. Several colonies of different sizes 488 were replica-plated on BHI agar containing neomycin alone and on plates containing neomycin 489 plus chloramphenicol to select against colonies that have lost the plasmid. Only colonies that 490 lost the plasmid (i.e. did not grow on the latter plate) were subjected to PCR amplification and 491 sequencing of the PCR product to confirm the presence of the intended mutation ( Fig. S1 and 492 Table S10 ). Confirmed mutants were then purified by streaking and selecting single colonies 493 over three consecutive nights. 494 495
Construction of pcrispr-cas-rnjB. The complementation plasmid pcrispr-cas-rnjB was 496
constructed using a two-piece Gibson assembly (Gibson et al., 2009 ). Briefly, rnjB was amplified 497 from the genome of S. epidermidis RP62a using primers L035 and L038 (Table S10) Table S1 . 532 533 Phage infection time-course assay. S. epidermidis RP62a cells were grown in TSB supplemented 534 with 5 mM CaCl2 to an OD600 of 0.3 -0.4 and infected with phage Andhra at a multiplicity of 535 infection (MOI) of 0.5. A control culture was also prepared by omitting Andhra. Control and 536 bacteria:phage mixtures were incubated at 37°C for 10 min (without agitation) to allow phage 537 absorption, and cells were pelleted at 5,000 x g for 5 minutes. The supernatant was discarded, 538 pellets were resuspended in 40 ml of fresh TSB, and pelleted again as above. Cells pellets were 539 resuspended in 40 ml of fresh TSB. 10 ml of this culture was harvested immediately (time = 0), 540 and the remaining culture was returned to 37°C with agitation. Additional 10-ml aliquots of Harvested cultures were immediately heat-killed at 95°C for 10 min, pelleted, and washed with 543 10 ml of sterile water. Final cell pellets were stored at -80°C for nucleic acid extraction. His10Smt3-rnjB were constructed using a two-piece Gibson assembly. Briefly, inserts were 592 obtained by amplifying rnjA and rnjB from the genome of S. epidermidis RP62a and amplifying 593 the backbone from a pET28b-His10Smt3 template using primers L030-L033 (for the rnjB aliquots each of IMAC buffer containing 50, 75, 100 and 500 mM imidazole. Proteins were 629 resolved and visualized as described above. Protein concentrations were determined using 630 absorbance measurements at 280 nm with a NanoDrop2000 spectrophotometer (ThermoFisher 631 Scientific) . 632
Statistical analyses and replicate definitions. All graphed data represent the mean (± S.D.) of n 659 replicates, where n is indicated in figure legends and Tables S1-S9. Average values were 660 analyzed using a one-tailed t-test, and p values below 0.05 were considered statistically 661 significant. No statistical methods were used to predetermine sample size. The following terms 662 are used to describe the types of repetitions where appropriate in figure legends and Tables S1-663 S9: technical replicate, independent trial, and biological replicate. Technical replicates refer to 664 multiple measurements taken on a single cell line in a single experiment; independent trials 665 refer to repetitions of the same experiment conducted at different times using the same cell 666 lines; and biological replicates refer to independent trials conducted on different lines of cells in 667 which each line comprises a transformant or mutant that was independently generated. Table S1 for source data. shown) into S. epidermidis LM1680 recipient strains containing pcrispr-cas, in which the first 890 spacer (green square) bears complementarity to pG0400. 891 (B) The indicated recipient strains harboring either pC194 (empty vector), pcrispr-cas, or 892 pcrispr-cas-rnjB (which encodes rnjB downstream of the CRISPR-Cas10 system) were mated 893 with S. aureus RN4220/pG0400. Cells were subsequently plated on selective media to 894 enumerate S. epidermidis recipients and transconjugants. Conjugation (conj.) efficiencies were 895 determined as the average numbers of transconjugants/recipients. Shown is a representative of 896 2-9 independent trials (see Table S2 for exact replicate numbers). The significant differences 897 between conjugation efficiencies observed for the wild-type strain in comparison to the DrnjB 898 and DpnpDrnjB mutants are indicated (t-test, one-tailed, p = 0.04 and 0.02, respectively). RP62a. In this assay, the genome-encoded CRISPR-Cas10 system works together with a spacer 907 encoded in the plasmid pcrispr-spcA2 (orange square) to protect against phage Andhra. 908 (F) The indicated strains were challenged with Andhra and the resulting pfu/ml were 909 enumerated. For both phage challenge assays, the data shown is an average (± S.D.) of three 910 technical replicates as a representative of several independent trials (see Tables S3 and S4 for  911 source data and numbers of trials). Dotted lines indicate the limits of detection for these assays. Table S10 for primer sequences). The genes were deleted from S. epidermidis 987 using the pKOR1 allelic replacement system (Bae et al). Following mutagenesis, deletions were 988 confirmed by amplifying genomic DNA using indicated primers. 989 nucleotides) in order to differentiate the knock-in strain from the original wild-type. The pnp 997 gene bearing these mutations was replaced into the Dpnp strain in its original genetic locus 998 using the pKOR1 allelic replacement system (Bae & Schneewind, 2006) . Following mutagenesis, 999 the insertion was confirmed by amplifying genomic DNA using primers F181 and F182 (see 1000 Table S10 for primer sequences). 1001 (B) PCR products from the indicated S. epidermidis LM1680 strains which confirm an insertion 1002 was introduced. Table S2 . Accompanies Figure 3B . Recipients, transconjugants, and conjugation efficiencies 1042 measured for various S. epidermidis LM1680 strains harbouring indicated plasmids. 1043 1044 Table S3 . Accompanies Figure 3D . CNPx plaque counts in pfu/mL when plated on various S. 1045 epidermidis LM1680 strains harbouring indicated plasmids. 1046 1047 Table S4 . Accompanies Figure 3F . Andhra plaque counts in pfu/mL when plated on various S. 1048 epidermidis RP62a strains harbouring indicated plasmids. 1049 Table S5 . Accompanies Figure 4B . Relative phage RNA abundance measured in indicated S. 1051 epidermidis RP62a strains following qRT-PCR analysis 1052 1053   Table S6 . Accompanies Figure 4C . Relative phage DNA abundance measured in indicated S. 1054 epidermidis RP62a strains following qPCR analysis 1055 1056 Table S7 . Accompanies Figure S3 . Relative phage DNA abundance measured in indicated S. 1057 epidermidis RP62a strains following qPCR analysis 1058 1059 Table S8 . Accompanies Figure 5D . 
